ACN structure
|
Common Name | ACN | ||
---|---|---|---|---|
CAS Number | 2797-51-5 | Molecular Weight | 207.613 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 310.2±42.0 °C at 760 mmHg | |
Molecular Formula | C10H6ClNO2 | Melting Point | 198-200 °C | |
MSDS | Chinese USA | Flash Point | 141.4±27.9 °C | |
Symbol |
GHS06, GHS09 |
Signal Word | Danger |
Use of ACNQuinoclamine, a naphthoquinone derivative, is a NF-κB inhibitor. Quinoclamine exhibits anti-cancer activity[1][2]. |
Name | quinoclamine |
---|---|
Synonym | More Synonyms |
Description | Quinoclamine, a naphthoquinone derivative, is a NF-κB inhibitor. Quinoclamine exhibits anti-cancer activity[1][2]. |
---|---|
Related Catalog | |
Target |
NF-κB[2] |
In Vitro | Quinoclamine causes differentiation of U-937 cells into macrophage-like cells[1]. Quinoclamine inhibits NF-κB activities in HepG2 cells, with an IC50 of 1.7 μM[2]. Quinoclamine (1-4 μM; 30 minutes ) suppresses endogenous NF-κB activity in HepG2 cells through the inhibition of IκB-α phosphorylation and p65 translocation[2]. Quinoclamine inhibits induced NF-κB activities in lung and breast cancer cell lines[2]. Quinoclamine affects the expression levels of genes involved in cell cycle or apoptosis[2]. Quinoclamine down-regulates the expressions of UDP glucuronosyltransferase genes involved in phase II drug metabolism[2]. Cell Viability Assay[2] Cell Line: HepG2 cells Concentration: 1 μM, 2 μM, 4 μM, 8 μM, 16 μM, 32 μM, 64 μM Incubation Time: 24 hours Result: Inhibited NF-κB activities in HepG2 cells. Western Blot Analysis[2] Cell Line: HepG2 cells Concentration: 0 μM, 1 μM, 2 μM, 4 μM Incubation Time: 30 minutes Result: Inhibited IκB-α phosphorylation and p65 translocation in HepG2 cells. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 310.2±42.0 °C at 760 mmHg |
Melting Point | 198-200 °C |
Molecular Formula | C10H6ClNO2 |
Molecular Weight | 207.613 |
Flash Point | 141.4±27.9 °C |
Exact Mass | 207.008713 |
PSA | 60.16000 |
LogP | 1.31 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.660 |
Storage condition | 0-6°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06, GHS09 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H319-H331-H400 |
Precautionary Statements | P261-P273-P305 + P351 + P338-P311 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T: Toxic; |
Risk Phrases | R36/37/38 |
Safety Phrases | S45-S37/39-S26 |
RIDADR | 2811.0 |
RTECS | QL7350000 |
HS Code | 2922399021 |
~77% ACN CAS#:2797-51-5 |
Literature: Hodnett, Ernest M.; Wongwiechintana, Chinda; Dunn, William J.; Marrs, Pam Journal of Medicinal Chemistry, 1983 , vol. 26, # 4 p. 570 - 574 |
~95% ACN CAS#:2797-51-5 |
Literature: Thapliyal, Prakash Chander Synthetic Communications, 1998 , vol. 28, # 7 p. 1123 - 1126 |
~% ACN CAS#:2797-51-5 |
Literature: ENZON PHARMACEUTICALS, INC. Patent: US2011/305769 A1, 2011 ; |
~% ACN CAS#:2797-51-5 |
Literature: Ullmann; Ettisch Chemische Berichte, 1921 , vol. 54, p. 271 |
~% ACN CAS#:2797-51-5 |
Literature: Shishkina, R. P.; Berezhnaya, V. N.; Fokin, E. P. Bulletin of the Academy of Sciences of the USSR, Division of Chemical Science (English Translation), 1985 , vol. 34, # 10 p. 2160 - 2164 Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1985 , # 10 p. 2332 - 2337 |
~% ACN CAS#:2797-51-5 |
Literature: Fries; Ochwat Chemische Berichte, 1923 , vol. 56, p. 1298 Full Text Show Details Ullmann; Ettisch Chemische Berichte, 1921 , vol. 54, p. 271 |
~% ACN CAS#:2797-51-5 |
Literature: Fries; Ochwat Chemische Berichte, 1923 , vol. 56, p. 1298 Full Text Show Details Ullmann; Ettisch Chemische Berichte, 1921 , vol. 54, p. 271 |
HS Code | 2922399021 |
---|---|
Summary | 2922399021 2-amino-3-chloronaphthalene-1,4-dione。supervision conditions:s(import or export registration certificate for pesticides)。VAT:17.0%。tax rebate rate:9.0%。MFN tarrif:6.5%。general tariff:30.0% |
Induction of differentiation of U-937 cells by 2-chloro-3-amino-1,4-naphthoquinone.
Res. Commun. Mol. Pathol. Pharmacol. 97(2) , 215-27, (1997) Naphthoquinone compounds have various pharmacological effects such as antiviral, antifungal and anticancer activities. We demonstrated the differentiation of the inducing effect of a naphthoquinone de... |
|
Differentiation inducing effects of 2-chloro-3-amino-1,4-naphthoquinone on human leukemia HL-60.
Biol. Pharm. Bull. 19(6) , 824-7, (1996) There are some highly cytotoxic anticancer compounds inducing differentiation of cancer cells to normal cells at below highly cytotoxic concentration. Naphthoquinone derivatives having cytotoxic effec... |
Quinoclamin |
Quinoclamine |
EINECS 220-529-2 |
2-AMINO-3-CHLORO-1,4-NAPHTHOQUINONE |
ACN |
2-amino-3-chloro-naphthoquinone |
2-Amino-3-chlor-1,4-naphthochinone |
06K-Quinone |
2-amino-3-chloronaphthalene-1,4-dione |
MFCD00001680 |
Mogeton |
1,4-Naphthalenedione, 2-amino-3-chloro- |
2-amino-3-chloro-1,4-dihydro-1,4-dioxonaphthalene |
ACNQ |
Mogeton granule |
O 6K-quinone |
2-amino-3-chloro-1,4-naphthalenedione |